GLP-1 medications are not recommended during pregnancy or breastfeeding, and some (like semaglutide) should be discontinued at least 2 months before a planned pregnancy
[16] reported that dipeptidyl-peptidase 4 (DPP-4) inhibition did not alter the GH/IGF-1 axis in adults with type 2 diabetes
The article states that DNA tests provide genetic information yet fail to confirm a histamine intolerance diagnosis, and that they uncover tendencies rather than deliver certainty
The amounts delivered by standard peptide protocols are far below toxic copper thresholds, but users with Wilson's disease or copper metabolism disorders should avoid copper peptides entirely
It is a different thing entirely from Hashimoto's thyroiditis, from post-surgical or post-ablation hypothyroidism, or from primary hypothyroidism of any cause
Semaglutide is a medication originally developed to help manage type 2 diabetes, but it has also been approved for weight loss in people who are overweight or have obesity